Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TSC2 |
| Variant | F615S |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | TSC2 F615S does not lie within any known functional domains of the Tsc2 protein (UniProt.org). F615S activates Rheb GTPase to similar levels of wild-type Tsc2 (PMID: 15483652) but results in decreased suppression of S6k phosphorylation (PMID: 15483652, PMID: 21309039, PMID: 14993219), reduced Tsc2 stability (PMID: 21309039), altered chaperone function, decreased Tsc1 binding, and decreased Tsc2 phosphorylation in culture (PMID: 11741832). |
| Associated Drug Resistance | |
| Category Variants Paths |
TSC2 mutant TSC2 inact mut TSC2 F615S |
| Transcript | NM_000548.5 |
| gDNA | chr16:g.2071514T>C |
| cDNA | c.1844T>C |
| Protein | p.F615S |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000548.5 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001406664.1 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001370404.1 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_021055.3 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_011522639.3 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001077183.3 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_011522637.3 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_005255529.4 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_024450413.1 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_017023615.1 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_011522637.2 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001077183.2 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_011522639.2 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_017023616.1 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001370405.1 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_000548.4 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_011522636.2 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_005255531.4 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001114382.2 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001363528.2 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_011522636.3 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001406665.1 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001406663.1 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| XM_011522640.2 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| NM_001114382.3 | chr16:g.2071514T>C | c.1844T>C | p.F615S | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|